Marian Rewers
Concepts (912)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 374 | 2025 | 3629 | 20.440 |
Why?
| Islets of Langerhans | 116 | 2025 | 791 | 11.470 |
Why?
| Autoantibodies | 181 | 2025 | 1468 | 11.210 |
Why?
| Autoimmunity | 127 | 2025 | 863 | 11.200 |
Why?
| Celiac Disease | 52 | 2024 | 286 | 7.220 |
Why?
| Genetic Predisposition to Disease | 91 | 2025 | 2271 | 4.200 |
Why?
| Coronary Artery Disease | 34 | 2018 | 680 | 3.480 |
Why?
| Diabetic Angiopathies | 28 | 2017 | 261 | 3.220 |
Why?
| Child, Preschool | 198 | 2025 | 10487 | 3.030 |
Why?
| Calcinosis | 23 | 2015 | 232 | 2.930 |
Why?
| HLA-DQ Antigens | 37 | 2020 | 179 | 2.870 |
Why?
| HLA-DR Antigens | 28 | 2021 | 223 | 2.790 |
Why?
| Insulin Resistance | 55 | 2018 | 1168 | 2.720 |
Why?
| Child | 225 | 2025 | 20882 | 2.700 |
Why?
| Insulin | 74 | 2025 | 2329 | 2.580 |
Why?
| Infant | 165 | 2025 | 8987 | 2.530 |
Why?
| Disease Progression | 80 | 2024 | 2628 | 2.490 |
Why?
| Risk Factors | 161 | 2025 | 9787 | 2.290 |
Why?
| Blood Glucose | 38 | 2022 | 2102 | 2.190 |
Why?
| Humans | 492 | 2025 | 129687 | 2.170 |
Why?
| Transglutaminases | 29 | 2024 | 153 | 2.100 |
Why?
| Genotype | 62 | 2023 | 1829 | 2.040 |
Why?
| Male | 333 | 2025 | 63691 | 2.000 |
Why?
| Prospective Studies | 98 | 2024 | 7145 | 2.000 |
Why?
| Female | 341 | 2025 | 68751 | 1.940 |
Why?
| Diabetic Ketoacidosis | 13 | 2024 | 197 | 1.820 |
Why?
| Polymorphism, Single Nucleotide | 36 | 2025 | 2062 | 1.810 |
Why?
| Adolescent | 134 | 2025 | 20415 | 1.740 |
Why?
| Biomarkers | 46 | 2023 | 3969 | 1.720 |
Why?
| Insulin Antibodies | 23 | 2024 | 105 | 1.710 |
Why?
| Diabetic Nephropathies | 19 | 2020 | 284 | 1.680 |
Why?
| Insulin-Secreting Cells | 15 | 2023 | 367 | 1.570 |
Why?
| Hyperglycemia | 10 | 2024 | 327 | 1.530 |
Why?
| Coronary Disease | 15 | 2010 | 385 | 1.510 |
Why?
| Glutamate Decarboxylase | 34 | 2023 | 166 | 1.500 |
Why?
| Prediabetic State | 14 | 2023 | 244 | 1.480 |
Why?
| Diet | 29 | 2024 | 1212 | 1.410 |
Why?
| Autoimmune Diseases | 16 | 2019 | 428 | 1.390 |
Why?
| Case-Control Studies | 57 | 2023 | 3381 | 1.380 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 10 | 2022 | 46 | 1.260 |
Why?
| HLA Antigens | 24 | 2025 | 235 | 1.260 |
Why?
| Follow-Up Studies | 62 | 2024 | 4892 | 1.250 |
Why?
| Glutens | 11 | 2023 | 57 | 1.220 |
Why?
| Mass Screening | 21 | 2024 | 1192 | 1.200 |
Why?
| Cohort Studies | 66 | 2022 | 5434 | 1.160 |
Why?
| Fatty Acids, Omega-3 | 8 | 2020 | 138 | 1.150 |
Why?
| Adult | 158 | 2025 | 35607 | 1.120 |
Why?
| Enterovirus Infections | 6 | 2023 | 171 | 1.100 |
Why?
| Diabetes Mellitus, Type 2 | 34 | 2022 | 2443 | 1.090 |
Why?
| Polymorphism, Genetic | 15 | 2019 | 636 | 1.070 |
Why?
| Environment | 5 | 2018 | 345 | 1.050 |
Why?
| H(+)-K(+)-Exchanging ATPase | 2 | 2017 | 15 | 1.000 |
Why?
| Infant, Newborn | 64 | 2025 | 5759 | 1.000 |
Why?
| Erythrocyte Membrane | 5 | 2015 | 49 | 0.990 |
Why?
| Middle Aged | 137 | 2025 | 31165 | 0.970 |
Why?
| Atherosclerosis | 15 | 2018 | 402 | 0.930 |
Why?
| Colorado | 44 | 2024 | 4405 | 0.930 |
Why?
| Incidence | 36 | 2022 | 2644 | 0.880 |
Why?
| Coronary Vessels | 8 | 2017 | 239 | 0.880 |
Why?
| Diabetes Complications | 7 | 2019 | 224 | 0.870 |
Why?
| Albuminuria | 12 | 2016 | 183 | 0.860 |
Why?
| Enterovirus | 5 | 2019 | 78 | 0.860 |
Why?
| HLA-DR3 Antigen | 16 | 2023 | 80 | 0.840 |
Why?
| Proportional Hazards Models | 26 | 2024 | 1199 | 0.840 |
Why?
| Longitudinal Studies | 27 | 2025 | 2724 | 0.810 |
Why?
| Vascular Calcification | 9 | 2018 | 107 | 0.800 |
Why?
| Age of Onset | 18 | 2025 | 494 | 0.800 |
Why?
| Predictive Value of Tests | 25 | 2019 | 1950 | 0.790 |
Why?
| Young Adult | 51 | 2025 | 12457 | 0.740 |
Why?
| Glucose Tolerance Test | 26 | 2022 | 355 | 0.740 |
Why?
| C-Peptide | 7 | 2025 | 163 | 0.730 |
Why?
| Breast Feeding | 18 | 2021 | 424 | 0.720 |
Why?
| Genetic Testing | 8 | 2019 | 422 | 0.710 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 12 | 2025 | 63 | 0.700 |
Why?
| HLA-DR4 Antigen | 16 | 2022 | 78 | 0.700 |
Why?
| Fatty Acids | 6 | 2021 | 427 | 0.700 |
Why?
| Blood Glucose Self-Monitoring | 6 | 2022 | 601 | 0.690 |
Why?
| Calcium | 8 | 2023 | 1212 | 0.670 |
Why?
| DNA Methylation | 5 | 2024 | 606 | 0.670 |
Why?
| Antibodies, Viral | 6 | 2023 | 602 | 0.660 |
Why?
| Haplotypes | 14 | 2025 | 474 | 0.650 |
Why?
| Autoantigens | 9 | 2025 | 420 | 0.640 |
Why?
| Vitamin D | 7 | 2018 | 380 | 0.630 |
Why?
| Prevalence | 23 | 2024 | 2563 | 0.610 |
Why?
| Zinc Transporter 8 | 7 | 2021 | 87 | 0.610 |
Why?
| Infant Nutritional Physiological Phenomena | 5 | 2021 | 137 | 0.600 |
Why?
| Cross-Sectional Studies | 36 | 2025 | 5083 | 0.600 |
Why?
| Seroconversion | 6 | 2021 | 46 | 0.590 |
Why?
| Uric Acid | 6 | 2018 | 161 | 0.590 |
Why?
| GTP-Binding Proteins | 7 | 2024 | 158 | 0.570 |
Why?
| Germany | 12 | 2024 | 100 | 0.560 |
Why?
| Logistic Models | 24 | 2017 | 1988 | 0.560 |
Why?
| Infant Food | 7 | 2018 | 65 | 0.550 |
Why?
| Health Care Costs | 1 | 2020 | 367 | 0.540 |
Why?
| Adiponectin | 5 | 2016 | 236 | 0.540 |
Why?
| Fatty Acids, Unsaturated | 2 | 2016 | 97 | 0.540 |
Why?
| Fibrinogen | 5 | 2019 | 164 | 0.540 |
Why?
| Edible Grain | 4 | 2008 | 48 | 0.530 |
Why?
| Metabolomics | 5 | 2021 | 652 | 0.530 |
Why?
| Monitoring, Physiologic | 2 | 2009 | 266 | 0.520 |
Why?
| Glomerular Filtration Rate | 15 | 2020 | 711 | 0.520 |
Why?
| Lipids | 5 | 2019 | 628 | 0.520 |
Why?
| Arteriosclerosis | 17 | 2004 | 89 | 0.510 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 399 | 0.510 |
Why?
| Hypoglycemia | 5 | 2014 | 427 | 0.500 |
Why?
| Inflammation | 8 | 2017 | 2748 | 0.500 |
Why?
| Sensitivity and Specificity | 21 | 2022 | 1844 | 0.500 |
Why?
| Age Factors | 37 | 2022 | 3153 | 0.480 |
Why?
| Triglycerides | 13 | 2020 | 528 | 0.480 |
Why?
| Milk | 7 | 2017 | 122 | 0.470 |
Why?
| Hypertension | 11 | 2021 | 1242 | 0.470 |
Why?
| Luminescent Measurements | 4 | 2021 | 76 | 0.470 |
Why?
| Finland | 15 | 2024 | 90 | 0.470 |
Why?
| Genome-Wide Association Study | 9 | 2025 | 1326 | 0.460 |
Why?
| Probiotics | 3 | 2022 | 51 | 0.460 |
Why?
| C-Reactive Protein | 5 | 2018 | 401 | 0.450 |
Why?
| Helicobacter Infections | 1 | 2014 | 29 | 0.450 |
Why?
| Helicobacter pylori | 1 | 2014 | 38 | 0.450 |
Why?
| Body Mass Index | 22 | 2023 | 2274 | 0.440 |
Why?
| Time Factors | 21 | 2018 | 6545 | 0.440 |
Why?
| Risk | 17 | 2020 | 855 | 0.440 |
Why?
| Prenatal Exposure Delayed Effects | 6 | 2021 | 573 | 0.440 |
Why?
| Antibodies | 5 | 2024 | 399 | 0.440 |
Why?
| Dietary Supplements | 7 | 2024 | 532 | 0.430 |
Why?
| Asymptomatic Diseases | 3 | 2023 | 84 | 0.430 |
Why?
| Fatty Acids, Monounsaturated | 2 | 2014 | 53 | 0.430 |
Why?
| Sweden | 13 | 2024 | 93 | 0.430 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 32 | 0.420 |
Why?
| Immunogenetics | 1 | 2013 | 7 | 0.420 |
Why?
| Alleles | 14 | 2021 | 843 | 0.420 |
Why?
| Risk Assessment | 17 | 2021 | 3260 | 0.410 |
Why?
| Dyslipidemias | 4 | 2015 | 177 | 0.410 |
Why?
| Bacteriophages | 2 | 2025 | 86 | 0.410 |
Why?
| Prognosis | 17 | 2021 | 3772 | 0.410 |
Why?
| Glucose Clamp Technique | 8 | 2020 | 194 | 0.410 |
Why?
| Smoking | 8 | 2019 | 1502 | 0.400 |
Why?
| HLA-D Antigens | 5 | 2019 | 34 | 0.400 |
Why?
| Dietary Fats | 3 | 2014 | 303 | 0.400 |
Why?
| Oxylipins | 3 | 2023 | 33 | 0.400 |
Why?
| Ascorbic Acid | 4 | 2023 | 120 | 0.390 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 104 | 0.390 |
Why?
| Fasting | 12 | 2015 | 267 | 0.390 |
Why?
| Lipoproteins | 4 | 2015 | 172 | 0.380 |
Why?
| Epitopes | 6 | 2025 | 474 | 0.380 |
Why?
| Vitamin D Deficiency | 2 | 2011 | 177 | 0.380 |
Why?
| Apolipoproteins A | 2 | 2006 | 19 | 0.370 |
Why?
| Early Diagnosis | 6 | 2020 | 233 | 0.370 |
Why?
| Hypoglycemic Agents | 8 | 2020 | 1220 | 0.370 |
Why?
| Liver | 3 | 2012 | 1839 | 0.360 |
Why?
| Addison Disease | 6 | 2012 | 43 | 0.360 |
Why?
| Adipocytes | 1 | 2012 | 205 | 0.360 |
Why?
| Sex Factors | 20 | 2020 | 1973 | 0.360 |
Why?
| Life Style | 5 | 2015 | 462 | 0.350 |
Why?
| Fetal Blood | 6 | 2021 | 318 | 0.350 |
Why?
| United States | 34 | 2024 | 13906 | 0.350 |
Why?
| Precision Medicine | 1 | 2014 | 385 | 0.350 |
Why?
| Hypolipidemic Agents | 2 | 2010 | 92 | 0.350 |
Why?
| Dietary Proteins | 4 | 2019 | 129 | 0.350 |
Why?
| Surveys and Questionnaires | 17 | 2024 | 5427 | 0.340 |
Why?
| Plant Proteins | 1 | 2011 | 89 | 0.340 |
Why?
| Cholesterol, HDL | 8 | 2015 | 205 | 0.340 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 713 | 0.340 |
Why?
| Epidemics | 1 | 2011 | 82 | 0.340 |
Why?
| Research | 2 | 2013 | 420 | 0.330 |
Why?
| Patient Education as Topic | 2 | 2005 | 743 | 0.330 |
Why?
| Eating | 5 | 2023 | 371 | 0.330 |
Why?
| Cesarean Section | 2 | 2024 | 182 | 0.330 |
Why?
| Blood Proteins | 3 | 2017 | 245 | 0.320 |
Why?
| CD4-Positive T-Lymphocytes | 5 | 2025 | 1058 | 0.320 |
Why?
| CTLA-4 Antigen | 5 | 2017 | 87 | 0.320 |
Why?
| Obesity | 12 | 2015 | 2885 | 0.320 |
Why?
| Steroid 21-Hydroxylase | 5 | 2012 | 30 | 0.320 |
Why?
| HLA-DQ beta-Chains | 12 | 2019 | 61 | 0.320 |
Why?
| Cystatin C | 6 | 2014 | 65 | 0.320 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 1005 | 0.310 |
Why?
| Gastrointestinal Microbiome | 3 | 2025 | 641 | 0.310 |
Why?
| Family Health | 8 | 2017 | 198 | 0.310 |
Why?
| Multivariate Analysis | 10 | 2016 | 1500 | 0.310 |
Why?
| Environmental Exposure | 3 | 2024 | 463 | 0.310 |
Why?
| Diet, Ketogenic | 1 | 2009 | 36 | 0.310 |
Why?
| Sex Distribution | 6 | 2011 | 359 | 0.300 |
Why?
| Antigens, CD | 2 | 2009 | 487 | 0.300 |
Why?
| Major Histocompatibility Complex | 5 | 2011 | 229 | 0.300 |
Why?
| Rotavirus | 2 | 2016 | 20 | 0.300 |
Why?
| Feces | 7 | 2025 | 442 | 0.300 |
Why?
| Diabetes Mellitus | 8 | 2009 | 1003 | 0.300 |
Why?
| Reproductive History | 1 | 2008 | 18 | 0.290 |
Why?
| Europe | 11 | 2021 | 363 | 0.290 |
Why?
| Tomography, X-Ray Computed | 12 | 2018 | 2510 | 0.290 |
Why?
| Angiotensin II Type 2 Receptor Blockers | 1 | 2007 | 7 | 0.280 |
Why?
| Cystatins | 1 | 2007 | 7 | 0.280 |
Why?
| Adiposity | 7 | 2020 | 504 | 0.280 |
Why?
| Diet, Gluten-Free | 3 | 2024 | 42 | 0.280 |
Why?
| Seroepidemiologic Studies | 4 | 2023 | 157 | 0.280 |
Why?
| Reference Values | 10 | 2012 | 796 | 0.280 |
Why?
| Iron | 3 | 2023 | 282 | 0.280 |
Why?
| Adipose Tissue | 4 | 2018 | 594 | 0.270 |
Why?
| Exercise | 4 | 2023 | 1933 | 0.270 |
Why?
| Gene-Environment Interaction | 5 | 2024 | 185 | 0.270 |
Why?
| Survival Analysis | 4 | 2021 | 1270 | 0.270 |
Why?
| Respiratory Tract Infections | 4 | 2017 | 376 | 0.270 |
Why?
| Metabolome | 2 | 2020 | 339 | 0.270 |
Why?
| Glycopeptides | 2 | 2018 | 43 | 0.270 |
Why?
| RNA, Viral | 3 | 2019 | 620 | 0.270 |
Why?
| Patient Compliance | 3 | 2023 | 568 | 0.270 |
Why?
| HLA-DRB1 Chains | 8 | 2019 | 108 | 0.260 |
Why?
| Pregnancy | 17 | 2024 | 6412 | 0.260 |
Why?
| Overweight | 3 | 2021 | 531 | 0.260 |
Why?
| Proteomics | 5 | 2021 | 1058 | 0.260 |
Why?
| Histocompatibility Antigens Class I | 5 | 2011 | 200 | 0.260 |
Why?
| Renin-Angiotensin System | 1 | 2007 | 82 | 0.260 |
Why?
| Aged | 45 | 2021 | 22101 | 0.260 |
Why?
| Rotavirus Infections | 1 | 2006 | 45 | 0.260 |
Why?
| Remission Induction | 2 | 2004 | 274 | 0.260 |
Why?
| Apolipoproteins C | 1 | 2006 | 6 | 0.260 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 198 | 0.260 |
Why?
| Contraception | 1 | 2008 | 153 | 0.250 |
Why?
| Regression Analysis | 15 | 2014 | 997 | 0.250 |
Why?
| Protein Tyrosine Phosphatases | 7 | 2006 | 165 | 0.250 |
Why?
| Infant Formula | 3 | 2019 | 74 | 0.250 |
Why?
| Cardiovascular Diseases | 8 | 2018 | 2008 | 0.250 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 64 | 0.240 |
Why?
| Gene Frequency | 10 | 2020 | 500 | 0.240 |
Why?
| Maternal Age | 3 | 2004 | 125 | 0.240 |
Why?
| Carotid Arteries | 5 | 1998 | 196 | 0.240 |
Why?
| Diet Records | 4 | 2019 | 80 | 0.240 |
Why?
| Proinsulin | 3 | 2014 | 52 | 0.240 |
Why?
| Thyroiditis, Autoimmune | 1 | 2025 | 15 | 0.240 |
Why?
| Histocompatibility Antigens Class II | 5 | 2011 | 363 | 0.240 |
Why?
| Immunotherapy | 1 | 2009 | 596 | 0.230 |
Why?
| Apolipoproteins | 3 | 2014 | 38 | 0.230 |
Why?
| Glucose Intolerance | 7 | 2013 | 142 | 0.230 |
Why?
| Plasminogen Activator Inhibitor 1 | 6 | 2017 | 84 | 0.230 |
Why?
| Abdominal Wall | 1 | 2004 | 23 | 0.230 |
Why?
| Antihypertensive Agents | 2 | 2007 | 485 | 0.230 |
Why?
| Linear Models | 7 | 2016 | 821 | 0.230 |
Why?
| Docosahexaenoic Acids | 3 | 2021 | 82 | 0.230 |
Why?
| Tobacco Smoke Pollution | 4 | 2019 | 231 | 0.230 |
Why?
| Health Surveys | 3 | 2018 | 494 | 0.230 |
Why?
| Hyperlipidemias | 1 | 2005 | 126 | 0.220 |
Why?
| Animals | 26 | 2022 | 35404 | 0.220 |
Why?
| Delivery, Obstetric | 2 | 2004 | 136 | 0.220 |
Why?
| Immunoglobulin A | 6 | 2024 | 201 | 0.220 |
Why?
| Bone Density | 2 | 2020 | 463 | 0.220 |
Why?
| Seasons | 5 | 2024 | 493 | 0.220 |
Why?
| Haptoglobins | 3 | 2013 | 53 | 0.220 |
Why?
| Vitamin B Complex | 1 | 2024 | 41 | 0.210 |
Why?
| Coronary Angiography | 2 | 2014 | 306 | 0.210 |
Why?
| Electrochemical Techniques | 2 | 2021 | 48 | 0.210 |
Why?
| Peptide Library | 1 | 2024 | 84 | 0.210 |
Why?
| Genetic Variation | 3 | 2021 | 937 | 0.210 |
Why?
| Alanine Transaminase | 2 | 2015 | 154 | 0.210 |
Why?
| Birth Weight | 4 | 2016 | 505 | 0.210 |
Why?
| Iron Overload | 1 | 2023 | 12 | 0.210 |
Why?
| Child Development | 2 | 2020 | 459 | 0.210 |
Why?
| Muscle, Skeletal | 2 | 2018 | 1644 | 0.210 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 373 | 0.210 |
Why?
| ROC Curve | 4 | 2019 | 503 | 0.200 |
Why?
| Alcohol Drinking | 1 | 2009 | 764 | 0.200 |
Why?
| Virus Diseases | 4 | 2021 | 210 | 0.200 |
Why?
| Kaplan-Meier Estimate | 4 | 2018 | 851 | 0.200 |
Why?
| Diabetic Retinopathy | 4 | 2016 | 179 | 0.200 |
Why?
| Pediatrics | 4 | 2020 | 1056 | 0.200 |
Why?
| Ketone Bodies | 2 | 2014 | 15 | 0.200 |
Why?
| Lipid Metabolism | 2 | 2019 | 503 | 0.200 |
Why?
| Mothers | 4 | 2021 | 731 | 0.190 |
Why?
| Costs and Cost Analysis | 2 | 2020 | 201 | 0.190 |
Why?
| Influenza, Human | 2 | 2022 | 602 | 0.190 |
Why?
| Peptides | 3 | 2024 | 926 | 0.190 |
Why?
| Micronutrients | 2 | 2017 | 88 | 0.190 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 430 | 0.190 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2021 | 169 | 0.190 |
Why?
| Parents | 6 | 2023 | 1316 | 0.190 |
Why?
| T-Lymphocytes | 3 | 2025 | 1937 | 0.190 |
Why?
| Chromosome Mapping | 3 | 2021 | 499 | 0.190 |
Why?
| Age Distribution | 5 | 2011 | 372 | 0.190 |
Why?
| Lipase | 1 | 2002 | 66 | 0.190 |
Why?
| Odds Ratio | 6 | 2015 | 1021 | 0.180 |
Why?
| Dietary Approaches To Stop Hypertension | 1 | 2021 | 12 | 0.180 |
Why?
| Promoter Regions, Genetic | 2 | 2006 | 1213 | 0.180 |
Why?
| Blood Pressure | 9 | 2014 | 1736 | 0.180 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 45 | 0.180 |
Why?
| Body Height | 3 | 2014 | 192 | 0.180 |
Why?
| Monitoring, Ambulatory | 2 | 2014 | 83 | 0.180 |
Why?
| Glycerol | 2 | 2012 | 92 | 0.180 |
Why?
| Receptors, Calcitriol | 2 | 2012 | 53 | 0.180 |
Why?
| Growth | 2 | 2016 | 59 | 0.180 |
Why?
| White Matter | 1 | 2023 | 135 | 0.180 |
Why?
| Mass Spectrometry | 3 | 2021 | 717 | 0.180 |
Why?
| Gestational Age | 3 | 2020 | 874 | 0.180 |
Why?
| Bacteria | 2 | 2025 | 814 | 0.180 |
Why?
| Polysaccharides | 2 | 2022 | 86 | 0.180 |
Why?
| F2-Isoprostanes | 2 | 2015 | 20 | 0.170 |
Why?
| Gastroenteritis | 2 | 2016 | 67 | 0.170 |
Why?
| Luminescence | 3 | 2016 | 37 | 0.170 |
Why?
| Vitamins | 2 | 2020 | 173 | 0.170 |
Why?
| Genomics | 2 | 2021 | 716 | 0.170 |
Why?
| HLA-B8 Antigen | 4 | 2012 | 14 | 0.170 |
Why?
| Ketosis | 1 | 2020 | 12 | 0.170 |
Why?
| Reproducibility of Results | 8 | 2021 | 3084 | 0.170 |
Why?
| Influenza Vaccines | 2 | 2017 | 533 | 0.170 |
Why?
| Neonatal Screening | 4 | 2020 | 163 | 0.170 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 151 | 0.170 |
Why?
| Dietary Sucrose | 1 | 2020 | 48 | 0.170 |
Why?
| Prodromal Symptoms | 1 | 2020 | 14 | 0.170 |
Why?
| Disease Susceptibility | 6 | 2020 | 334 | 0.170 |
Why?
| Mannose | 1 | 2019 | 25 | 0.170 |
Why?
| Sugars | 1 | 2020 | 36 | 0.170 |
Why?
| Biopsy | 5 | 2017 | 1087 | 0.160 |
Why?
| Energy Intake | 5 | 2023 | 462 | 0.160 |
Why?
| Kidney | 2 | 2018 | 1383 | 0.160 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.160 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 587 | 0.160 |
Why?
| Developing Countries | 2 | 1993 | 284 | 0.160 |
Why?
| Life Change Events | 1 | 2021 | 149 | 0.160 |
Why?
| Oxidative Stress | 3 | 2017 | 1264 | 0.160 |
Why?
| Interferon-gamma | 2 | 2021 | 773 | 0.160 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 80 | 0.160 |
Why?
| Phospholipids | 1 | 2021 | 216 | 0.160 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 367 | 0.160 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 117 | 0.160 |
Why?
| Epidemiologic Methods | 4 | 2014 | 74 | 0.160 |
Why?
| Iodide Peroxidase | 5 | 2025 | 28 | 0.160 |
Why?
| Apolipoproteins B | 2 | 2015 | 43 | 0.160 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 836 | 0.160 |
Why?
| Butyrates | 1 | 2019 | 57 | 0.160 |
Why?
| Measles | 1 | 2019 | 44 | 0.160 |
Why?
| Cation Transport Proteins | 3 | 2011 | 131 | 0.150 |
Why?
| Osteoporotic Fractures | 1 | 2020 | 57 | 0.150 |
Why?
| Glycosuria | 2 | 2009 | 8 | 0.150 |
Why?
| Fatty Acids, Omega-6 | 4 | 2020 | 47 | 0.150 |
Why?
| Antibodies, Bacterial | 1 | 2019 | 139 | 0.150 |
Why?
| Uromodulin | 1 | 2018 | 21 | 0.150 |
Why?
| Genes, MHC Class II | 3 | 2012 | 73 | 0.150 |
Why?
| Cholesterol | 5 | 2014 | 412 | 0.150 |
Why?
| Genetic Markers | 4 | 2013 | 334 | 0.150 |
Why?
| Cotinine | 1 | 2019 | 75 | 0.150 |
Why?
| Models, Biological | 5 | 2019 | 1724 | 0.150 |
Why?
| Mexican Americans | 3 | 2014 | 113 | 0.150 |
Why?
| Health Expenditures | 1 | 2020 | 180 | 0.150 |
Why?
| HLA-DP beta-Chains | 3 | 2015 | 84 | 0.150 |
Why?
| Self Report | 3 | 2020 | 800 | 0.150 |
Why?
| Cost-Benefit Analysis | 2 | 2020 | 569 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 249 | 0.140 |
Why?
| Sodium Bicarbonate | 1 | 2018 | 37 | 0.140 |
Why?
| High-Throughput Screening Assays | 1 | 2019 | 139 | 0.140 |
Why?
| Squalene | 1 | 2017 | 7 | 0.140 |
Why?
| Amino Acid Sequence | 6 | 2024 | 2057 | 0.140 |
Why?
| HLA-DR2 Antigen | 2 | 2012 | 7 | 0.140 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.140 |
Why?
| Cost of Illness | 1 | 2020 | 277 | 0.140 |
Why?
| Feeding Behavior | 3 | 2013 | 626 | 0.140 |
Why?
| Phenotype | 8 | 2024 | 3062 | 0.140 |
Why?
| Antipyretics | 1 | 2017 | 5 | 0.140 |
Why?
| Gene Expression Profiling | 5 | 2017 | 1686 | 0.140 |
Why?
| Immunologic Memory | 1 | 2019 | 349 | 0.140 |
Why?
| Kidney Diseases | 2 | 2012 | 382 | 0.140 |
Why?
| Body Composition | 3 | 2020 | 649 | 0.140 |
Why?
| Immune Tolerance | 1 | 2019 | 356 | 0.140 |
Why?
| Blood Cell Count | 1 | 2017 | 53 | 0.140 |
Why?
| Radioimmunoassay | 6 | 2016 | 175 | 0.140 |
Why?
| Immunization | 1 | 1999 | 411 | 0.140 |
Why?
| Rheumatoid Factor | 3 | 2007 | 167 | 0.140 |
Why?
| Rural Health | 2 | 2002 | 71 | 0.130 |
Why?
| Osteoporosis | 1 | 2020 | 231 | 0.130 |
Why?
| Models, Genetic | 2 | 2017 | 592 | 0.130 |
Why?
| Genetic Loci | 3 | 2015 | 274 | 0.130 |
Why?
| Poland | 4 | 2010 | 31 | 0.130 |
Why?
| Proteins | 2 | 2021 | 944 | 0.130 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 59 | 0.130 |
Why?
| Milk Proteins | 1 | 1996 | 34 | 0.130 |
Why?
| Cytokines | 4 | 2017 | 2022 | 0.130 |
Why?
| Toxins, Biological | 1 | 2016 | 11 | 0.130 |
Why?
| Immunoglobulin G | 4 | 2021 | 851 | 0.130 |
Why?
| Body Weight | 3 | 2016 | 947 | 0.130 |
Why?
| Homozygote | 5 | 2014 | 195 | 0.130 |
Why?
| Models, Theoretical | 2 | 2017 | 549 | 0.130 |
Why?
| Arachidonic Acid | 2 | 2021 | 115 | 0.130 |
Why?
| Vitamin B 12 | 1 | 2017 | 121 | 0.130 |
Why?
| Hygiene | 1 | 2016 | 29 | 0.130 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 7 | 2006 | 47 | 0.130 |
Why?
| HLA-A1 Antigen | 2 | 2006 | 4 | 0.130 |
Why?
| HLA-DP Antigens | 2 | 2007 | 32 | 0.130 |
Why?
| Polymerase Chain Reaction | 5 | 2011 | 1033 | 0.120 |
Why?
| Diet Surveys | 4 | 2021 | 92 | 0.120 |
Why?
| Anorexia Nervosa | 1 | 2017 | 84 | 0.120 |
Why?
| Renal Insufficiency, Chronic | 3 | 2018 | 567 | 0.120 |
Why?
| Analgesics, Non-Narcotic | 1 | 2017 | 121 | 0.120 |
Why?
| Practice Guidelines as Topic | 1 | 2023 | 1506 | 0.120 |
Why?
| Lentigo | 1 | 2015 | 6 | 0.120 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.120 |
Why?
| Oxygen | 1 | 2020 | 916 | 0.120 |
Why?
| Stress, Psychological | 2 | 2021 | 1070 | 0.120 |
Why?
| Erythrocytes | 1 | 2021 | 673 | 0.120 |
Why?
| Histocompatibility Testing | 6 | 2017 | 121 | 0.120 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 756 | 0.120 |
Why?
| Absorptiometry, Photon | 2 | 2020 | 247 | 0.120 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 486 | 0.120 |
Why?
| Medical Records | 2 | 2007 | 171 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 51 | 0.120 |
Why?
| Complement C3 | 1 | 2016 | 208 | 0.120 |
Why?
| Child Day Care Centers | 1 | 2015 | 32 | 0.120 |
Why?
| Carbohydrates | 1 | 2015 | 64 | 0.120 |
Why?
| Genetic Association Studies | 4 | 2020 | 357 | 0.120 |
Why?
| Periodontal Diseases | 1 | 2015 | 61 | 0.120 |
Why?
| Up-Regulation | 2 | 2016 | 836 | 0.110 |
Why?
| International Agencies | 1 | 2014 | 29 | 0.110 |
Why?
| Gram-Positive Bacteria | 1 | 2014 | 44 | 0.110 |
Why?
| Fructosamine | 1 | 2014 | 15 | 0.110 |
Why?
| Gram-Negative Bacteria | 1 | 2014 | 69 | 0.110 |
Why?
| Health Records, Personal | 1 | 2014 | 26 | 0.110 |
Why?
| Acetaminophen | 1 | 2017 | 247 | 0.110 |
Why?
| Societies, Scientific | 1 | 2014 | 45 | 0.110 |
Why?
| Carotid Artery Diseases | 3 | 2000 | 64 | 0.110 |
Why?
| Dairy Products | 1 | 2014 | 36 | 0.110 |
Why?
| Genetic Linkage | 2 | 2015 | 296 | 0.110 |
Why?
| Adolescent Medicine | 1 | 2014 | 36 | 0.110 |
Why?
| Renal Insufficiency | 1 | 2016 | 149 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2015 | 2833 | 0.110 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.110 |
Why?
| Bias | 1 | 2015 | 197 | 0.110 |
Why?
| Eicosapentaenoic Acid | 1 | 2013 | 36 | 0.110 |
Why?
| Hemodynamics | 1 | 2018 | 1091 | 0.110 |
Why?
| Cholesterol, Dietary | 1 | 2013 | 18 | 0.110 |
Why?
| Patient Care Planning | 1 | 2014 | 146 | 0.100 |
Why?
| Eggs | 1 | 2013 | 25 | 0.100 |
Why?
| Siblings | 3 | 2018 | 216 | 0.100 |
Why?
| Mice | 11 | 2022 | 16982 | 0.100 |
Why?
| Gene Expression | 3 | 2021 | 1465 | 0.100 |
Why?
| Epigenesis, Genetic | 3 | 2024 | 615 | 0.100 |
Why?
| Hypoxia | 1 | 2020 | 1085 | 0.100 |
Why?
| Creatinine | 4 | 2018 | 490 | 0.100 |
Why?
| Phosphates | 1 | 2014 | 181 | 0.100 |
Why?
| Tumor Suppressor Proteins | 1 | 2015 | 311 | 0.100 |
Why?
| Biological Specimen Banks | 1 | 2013 | 96 | 0.100 |
Why?
| Communicable Diseases | 1 | 2015 | 152 | 0.100 |
Why?
| Heart Rate | 3 | 2010 | 803 | 0.100 |
Why?
| Sex Characteristics | 7 | 2015 | 735 | 0.100 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.100 |
Why?
| Pilot Projects | 4 | 2023 | 1594 | 0.100 |
Why?
| Monoamine Oxidase | 1 | 2012 | 27 | 0.100 |
Why?
| Immunity, Innate | 2 | 2022 | 804 | 0.100 |
Why?
| Research Support as Topic | 1 | 2013 | 112 | 0.100 |
Why?
| History, 21st Century | 1 | 2013 | 185 | 0.100 |
Why?
| Specimen Handling | 1 | 2013 | 163 | 0.100 |
Why?
| Receptors, Antigen, T-Cell | 3 | 2023 | 707 | 0.100 |
Why?
| Chromosomes, Human, Pair 2 | 2 | 2009 | 28 | 0.100 |
Why?
| Organizational Innovation | 1 | 2013 | 139 | 0.100 |
Why?
| Proteome | 1 | 2016 | 440 | 0.100 |
Why?
| Stomach | 1 | 2012 | 109 | 0.100 |
Why?
| CpG Islands | 2 | 2023 | 152 | 0.100 |
Why?
| Epistasis, Genetic | 1 | 2012 | 70 | 0.100 |
Why?
| Viruses | 1 | 2013 | 100 | 0.100 |
Why?
| History, 20th Century | 1 | 2013 | 293 | 0.100 |
Why?
| Interleukin-4 | 2 | 2005 | 212 | 0.090 |
Why?
| Lymphocytes | 1 | 2014 | 377 | 0.090 |
Why?
| Nuclear Family | 2 | 2009 | 51 | 0.090 |
Why?
| Intestine, Small | 2 | 2005 | 151 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2016 | 820 | 0.090 |
Why?
| Patient Selection | 3 | 2011 | 660 | 0.090 |
Why?
| Histocompatibility Antigens | 2 | 2013 | 107 | 0.090 |
Why?
| Hyperinsulinism | 2 | 2010 | 119 | 0.090 |
Why?
| Pedigree | 4 | 2017 | 483 | 0.090 |
Why?
| Intestines | 1 | 2014 | 349 | 0.090 |
Why?
| Calcifediol | 1 | 2011 | 31 | 0.090 |
Why?
| Primary Prevention | 1 | 2013 | 190 | 0.090 |
Why?
| Consensus | 2 | 2024 | 617 | 0.090 |
Why?
| Toll-Like Receptors | 1 | 2012 | 179 | 0.090 |
Why?
| Combined Modality Therapy | 1 | 2014 | 1201 | 0.090 |
Why?
| Gliadin | 2 | 2009 | 13 | 0.090 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 23 | 0.090 |
Why?
| Vaccines | 1 | 2016 | 400 | 0.090 |
Why?
| HLA-B Antigens | 1 | 2011 | 62 | 0.090 |
Why?
| Kidney Function Tests | 1 | 2011 | 152 | 0.090 |
Why?
| Vitamin D-Binding Protein | 1 | 2010 | 15 | 0.090 |
Why?
| Interleukin-2 | 1 | 2012 | 437 | 0.090 |
Why?
| Vascular Diseases | 2 | 2013 | 240 | 0.090 |
Why?
| Thyroglobulin | 3 | 2025 | 27 | 0.090 |
Why?
| Video Recording | 1 | 2011 | 164 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2017 | 2014 | 0.090 |
Why?
| Weight Gain | 2 | 2011 | 510 | 0.090 |
Why?
| Food, Fortified | 1 | 2010 | 37 | 0.090 |
Why?
| Endocrine Cells | 1 | 2010 | 7 | 0.090 |
Why?
| Milk, Human | 3 | 2018 | 151 | 0.090 |
Why?
| Decision Support Techniques | 2 | 2013 | 398 | 0.090 |
Why?
| Gastrointestinal Diseases | 1 | 2012 | 198 | 0.090 |
Why?
| Linkage Disequilibrium | 4 | 2015 | 257 | 0.090 |
Why?
| Myocardial Infarction | 2 | 1994 | 1021 | 0.080 |
Why?
| Interleukin-1beta | 1 | 2012 | 369 | 0.080 |
Why?
| Abdomen | 1 | 2010 | 118 | 0.080 |
Why?
| Nutrition Assessment | 2 | 2015 | 86 | 0.080 |
Why?
| Family | 5 | 2018 | 646 | 0.080 |
Why?
| Microbiota | 2 | 2014 | 734 | 0.080 |
Why?
| Lymphocyte Activation | 1 | 2014 | 1110 | 0.080 |
Why?
| Fatty Acids, Nonesterified | 1 | 2010 | 160 | 0.080 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1214 | 0.080 |
Why?
| RNA | 1 | 2016 | 876 | 0.080 |
Why?
| Membrane Proteins | 3 | 2002 | 1119 | 0.080 |
Why?
| Leukocytes, Mononuclear | 2 | 2012 | 546 | 0.080 |
Why?
| Monitoring, Immunologic | 1 | 2009 | 23 | 0.080 |
Why?
| Transcription Factors | 1 | 2017 | 1645 | 0.080 |
Why?
| Quality Control | 3 | 2013 | 162 | 0.080 |
Why?
| Pancreas | 2 | 2023 | 305 | 0.080 |
Why?
| Metabolic Syndrome | 1 | 2013 | 340 | 0.080 |
Why?
| Waist-Hip Ratio | 2 | 2009 | 35 | 0.080 |
Why?
| Homeostasis | 2 | 2010 | 605 | 0.080 |
Why?
| Sequence Analysis, DNA | 3 | 2011 | 778 | 0.080 |
Why?
| Bifidobacterium | 2 | 2018 | 21 | 0.080 |
Why?
| Antigens, Viral | 2 | 2021 | 179 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2016 | 541 | 0.080 |
Why?
| Spleen | 1 | 2010 | 508 | 0.070 |
Why?
| Proteinuria | 1 | 2009 | 91 | 0.070 |
Why?
| Glycemic Index | 1 | 2008 | 25 | 0.070 |
Why?
| Isoenzymes | 2 | 2006 | 301 | 0.070 |
Why?
| Telomere | 3 | 2022 | 232 | 0.070 |
Why?
| Environmental Monitoring | 1 | 2010 | 309 | 0.070 |
Why?
| Interleukin-6 | 1 | 2012 | 724 | 0.070 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 66 | 0.070 |
Why?
| Laboratories | 1 | 2009 | 109 | 0.070 |
Why?
| Insulin Infusion Systems | 2 | 2017 | 363 | 0.070 |
Why?
| Disease Outbreaks | 2 | 1991 | 349 | 0.070 |
Why?
| Anti-Bacterial Agents | 1 | 2017 | 1708 | 0.070 |
Why?
| Angiotensins | 1 | 2007 | 9 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 291 | 0.070 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 22 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2008 | 127 | 0.070 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 524 | 0.070 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2007 | 53 | 0.070 |
Why?
| Contraceptive Agents, Female | 1 | 2008 | 78 | 0.070 |
Why?
| Antidepressive Agents | 1 | 2009 | 229 | 0.070 |
Why?
| Clinical Laboratory Techniques | 1 | 2007 | 94 | 0.070 |
Why?
| Pediatric Obesity | 1 | 2014 | 573 | 0.070 |
Why?
| Population Surveillance | 3 | 2020 | 439 | 0.070 |
Why?
| Datasets as Topic | 2 | 2018 | 109 | 0.070 |
Why?
| Microsatellite Repeats | 2 | 2009 | 163 | 0.070 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.070 |
Why?
| Drug Utilization | 2 | 2017 | 171 | 0.070 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 31 | 0.060 |
Why?
| Antibody Specificity | 4 | 2011 | 185 | 0.060 |
Why?
| Apolipoprotein C-III | 1 | 2006 | 13 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 2 | 2018 | 541 | 0.060 |
Why?
| Epitope Mapping | 2 | 2024 | 58 | 0.060 |
Why?
| Birth Order | 2 | 2004 | 13 | 0.060 |
Why?
| Adenovirus Infections, Human | 1 | 2005 | 14 | 0.060 |
Why?
| Carrier State | 1 | 2006 | 60 | 0.060 |
Why?
| Neoplasm Proteins | 2 | 2020 | 417 | 0.060 |
Why?
| Paired Box Transcription Factors | 1 | 2005 | 40 | 0.060 |
Why?
| Metagenomics | 2 | 2019 | 156 | 0.060 |
Why?
| Adenoviruses, Human | 1 | 2005 | 27 | 0.060 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.060 |
Why?
| Chronic Disease | 4 | 2017 | 1723 | 0.060 |
Why?
| Codon, Terminator | 1 | 2005 | 21 | 0.060 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 421 | 0.060 |
Why?
| Chromatography, Liquid | 3 | 2012 | 425 | 0.060 |
Why?
| Antigens, Differentiation | 1 | 2005 | 82 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2006 | 284 | 0.060 |
Why?
| Codon, Nonsense | 1 | 2005 | 40 | 0.060 |
Why?
| Protective Factors | 2 | 2015 | 91 | 0.060 |
Why?
| Capsid Proteins | 1 | 2005 | 90 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2018 | 4076 | 0.060 |
Why?
| Registries | 7 | 2019 | 1896 | 0.060 |
Why?
| Fathers | 1 | 2005 | 50 | 0.060 |
Why?
| Research Design | 3 | 2019 | 1045 | 0.060 |
Why?
| Survivors | 1 | 2008 | 462 | 0.060 |
Why?
| Transcriptome | 2 | 2023 | 875 | 0.060 |
Why?
| Radiography, Abdominal | 1 | 2004 | 46 | 0.060 |
Why?
| Interleukin-13 | 1 | 2005 | 147 | 0.060 |
Why?
| CD3 Complex | 1 | 2024 | 102 | 0.060 |
Why?
| RNA, Ribosomal, 16S | 2 | 2018 | 524 | 0.060 |
Why?
| Norway | 2 | 2019 | 42 | 0.060 |
Why?
| Nutritional Status | 1 | 2007 | 328 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 53 | 0.060 |
Why?
| Pennsylvania | 2 | 2018 | 108 | 0.060 |
Why?
| Postmenopause | 3 | 2020 | 349 | 0.060 |
Why?
| Cattle | 3 | 2017 | 978 | 0.060 |
Why?
| Anthropometry | 1 | 2004 | 204 | 0.060 |
Why?
| Waist Circumference | 2 | 2015 | 138 | 0.050 |
Why?
| Metagenome | 1 | 2025 | 140 | 0.050 |
Why?
| Insulin, Isophane | 1 | 2003 | 21 | 0.050 |
Why?
| DNA | 2 | 2011 | 1406 | 0.050 |
Why?
| Cross-Cultural Comparison | 2 | 2015 | 82 | 0.050 |
Why?
| Confidence Intervals | 1 | 2004 | 317 | 0.050 |
Why?
| International Cooperation | 3 | 2016 | 175 | 0.050 |
Why?
| Biomedical Research | 1 | 2009 | 640 | 0.050 |
Why?
| GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 21 | 0.050 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2022 | 336 | 0.050 |
Why?
| Aspartic Acid | 1 | 2023 | 80 | 0.050 |
Why?
| Creatine | 1 | 2023 | 58 | 0.050 |
Why?
| Peptides, Cyclic | 1 | 2005 | 256 | 0.050 |
Why?
| Glycomics | 1 | 2022 | 7 | 0.050 |
Why?
| Markov Chains | 2 | 2020 | 117 | 0.050 |
Why?
| Mice, Knockout | 1 | 2009 | 2888 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2023 | 110 | 0.050 |
Why?
| Renal Dialysis | 1 | 2006 | 423 | 0.050 |
Why?
| HLA-DQ alpha-Chains | 2 | 2019 | 16 | 0.050 |
Why?
| Electrocardiography | 2 | 2010 | 611 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2025 | 457 | 0.050 |
Why?
| Candida | 1 | 2022 | 37 | 0.050 |
Why?
| Choline | 1 | 2023 | 122 | 0.050 |
Why?
| HLA-B15 Antigen | 2 | 2012 | 13 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2023 | 287 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2005 | 493 | 0.050 |
Why?
| Prenatal Care | 1 | 2004 | 277 | 0.050 |
Why?
| Insulins | 1 | 2022 | 37 | 0.050 |
Why?
| Electrochemistry | 1 | 2021 | 79 | 0.050 |
Why?
| Retrospective Studies | 5 | 2025 | 14525 | 0.050 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
| China | 1 | 2021 | 192 | 0.040 |
Why?
| Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| Immunoglobulin D | 1 | 2021 | 29 | 0.040 |
Why?
| Perception | 1 | 2023 | 347 | 0.040 |
Why?
| Fungi | 1 | 2022 | 136 | 0.040 |
Why?
| Serologic Tests | 1 | 2021 | 52 | 0.040 |
Why?
| p-Aminohippuric Acid | 1 | 2020 | 6 | 0.040 |
Why?
| Protein Interaction Mapping | 1 | 2021 | 107 | 0.040 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 109 | 0.040 |
Why?
| Iohexol | 1 | 2020 | 19 | 0.040 |
Why?
| Furosemide | 1 | 2020 | 39 | 0.040 |
Why?
| Benchmarking | 1 | 2022 | 176 | 0.040 |
Why?
| Models, Statistical | 3 | 2015 | 624 | 0.040 |
Why?
| Isotopes | 1 | 2020 | 32 | 0.040 |
Why?
| Dehydroascorbic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| Drug Discovery | 1 | 2021 | 131 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 2017 | 766 | 0.040 |
Why?
| Kidney Transplantation | 1 | 2006 | 670 | 0.040 |
Why?
| Viral Proteins | 2 | 2006 | 327 | 0.040 |
Why?
| Growth Charts | 1 | 2020 | 14 | 0.040 |
Why?
| Amino Acids, Branched-Chain | 1 | 2020 | 36 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 12 | 0.040 |
Why?
| Antibody Diversity | 1 | 2019 | 16 | 0.040 |
Why?
| Antibodies, Heterophile | 1 | 1999 | 14 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 106 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 128 | 0.040 |
Why?
| Machine Learning | 1 | 2025 | 441 | 0.040 |
Why?
| Peroxidase | 1 | 2020 | 175 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2022 | 187 | 0.040 |
Why?
| Depression | 1 | 2009 | 1322 | 0.040 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 25 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2020 | 74 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 56 | 0.040 |
Why?
| Algorithms | 2 | 2018 | 1616 | 0.040 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 41 | 0.040 |
Why?
| Femur Neck | 1 | 2020 | 60 | 0.040 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 28 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2023 | 569 | 0.040 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 28 | 0.040 |
Why?
| Proline | 1 | 2020 | 76 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2021 | 276 | 0.040 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 47 | 0.040 |
Why?
| Efficiency | 1 | 2020 | 92 | 0.040 |
Why?
| Chromatography, Reverse-Phase | 1 | 2019 | 27 | 0.040 |
Why?
| Methionine | 1 | 2020 | 155 | 0.040 |
Why?
| Alanine | 1 | 2020 | 143 | 0.040 |
Why?
| Texas | 2 | 2014 | 237 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 131 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 330 | 0.040 |
Why?
| Macaca mulatta | 1 | 2019 | 150 | 0.040 |
Why?
| Pediatricians | 1 | 2020 | 129 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 74 | 0.040 |
Why?
| Bayes Theorem | 1 | 2021 | 374 | 0.040 |
Why?
| Proteobacteria | 1 | 2018 | 15 | 0.040 |
Why?
| Receptor, Insulin | 1 | 1999 | 99 | 0.040 |
Why?
| Adenoviridae | 1 | 2019 | 193 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 581 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 280 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 2018 | 49 | 0.040 |
Why?
| gamma-Aminobutyric Acid | 1 | 2020 | 168 | 0.040 |
Why?
| Firmicutes | 1 | 2018 | 18 | 0.040 |
Why?
| Alternative Splicing | 1 | 2000 | 216 | 0.040 |
Why?
| Phosphoproteins | 1 | 2021 | 333 | 0.040 |
Why?
| Pets | 1 | 2018 | 25 | 0.040 |
Why?
| Down-Regulation | 1 | 2021 | 631 | 0.040 |
Why?
| Lipocalin-2 | 1 | 2018 | 75 | 0.040 |
Why?
| Emotional Adjustment | 1 | 2018 | 16 | 0.040 |
Why?
| Fatty Acids, Volatile | 1 | 2018 | 57 | 0.040 |
Why?
| Microscopy, Polarization | 1 | 2018 | 31 | 0.040 |
Why?
| Interleukins | 1 | 2020 | 241 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2021 | 391 | 0.040 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.040 |
Why?
| Employment | 1 | 2020 | 167 | 0.040 |
Why?
| Postpartum Period | 1 | 2021 | 331 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2016 | 2739 | 0.040 |
Why?
| Osmolar Concentration | 1 | 2018 | 166 | 0.040 |
Why?
| Lumbar Vertebrae | 1 | 2020 | 234 | 0.040 |
Why?
| Apolipoprotein A-I | 1 | 1997 | 28 | 0.040 |
Why?
| Feasibility Studies | 2 | 2015 | 869 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2017 | 38 | 0.040 |
Why?
| Quantitative Trait Loci | 1 | 2020 | 352 | 0.040 |
Why?
| Estrogen Replacement Therapy | 1 | 1998 | 137 | 0.040 |
Why?
| Collagen | 1 | 2020 | 438 | 0.040 |
Why?
| Canada | 1 | 2018 | 353 | 0.030 |
Why?
| Discriminant Analysis | 1 | 2017 | 39 | 0.030 |
Why?
| Longevity | 1 | 2018 | 155 | 0.030 |
Why?
| United Kingdom | 1 | 2018 | 258 | 0.030 |
Why?
| Bicarbonates | 1 | 2017 | 42 | 0.030 |
Why?
| Vitamin E | 1 | 1997 | 120 | 0.030 |
Why?
| Receptor, ErbB-3 | 1 | 2017 | 44 | 0.030 |
Why?
| Vascular Resistance | 1 | 2018 | 371 | 0.030 |
Why?
| Biopsy, Needle | 2 | 2011 | 187 | 0.030 |
Why?
| Galactosamine | 1 | 2016 | 3 | 0.030 |
Why?
| Cluster Analysis | 1 | 2018 | 482 | 0.030 |
Why?
| Lipoprotein(a) | 1 | 1997 | 67 | 0.030 |
Why?
| Acetylglucosamine | 1 | 2016 | 10 | 0.030 |
Why?
| Pelvic Bones | 1 | 2020 | 156 | 0.030 |
Why?
| Random Allocation | 1 | 2018 | 347 | 0.030 |
Why?
| Molecular Weight | 2 | 2012 | 330 | 0.030 |
Why?
| Disease Management | 1 | 2020 | 588 | 0.030 |
Why?
| Africa | 2 | 1996 | 99 | 0.030 |
Why?
| Anxiety | 1 | 2023 | 976 | 0.030 |
Why?
| Regional Blood Flow | 1 | 2018 | 463 | 0.030 |
Why?
| Rotavirus Vaccines | 1 | 2016 | 49 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 76 | 0.030 |
Why?
| Anemia, Sickle Cell | 1 | 2000 | 253 | 0.030 |
Why?
| Protein Domains | 1 | 2017 | 254 | 0.030 |
Why?
| Antibody Affinity | 1 | 2016 | 59 | 0.030 |
Why?
| Vitreoretinopathy, Proliferative | 1 | 2016 | 14 | 0.030 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 146 | 0.030 |
Why?
| Quality of Life | 2 | 2024 | 2694 | 0.030 |
Why?
| Genetic Background | 1 | 2015 | 10 | 0.030 |
Why?
| Organ Specificity | 2 | 2007 | 295 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 646 | 0.030 |
Why?
| Membrane Glycoproteins | 1 | 1998 | 477 | 0.030 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 82 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2013 | 1248 | 0.030 |
Why?
| Georgia | 1 | 2015 | 80 | 0.030 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 576 | 0.030 |
Why?
| Analysis of Variance | 3 | 2010 | 1290 | 0.030 |
Why?
| DNA Primers | 1 | 1996 | 508 | 0.030 |
Why?
| Florida | 1 | 2015 | 93 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 271 | 0.030 |
Why?
| Genes | 1 | 1995 | 225 | 0.030 |
Why?
| Radioligand Assay | 2 | 2009 | 48 | 0.030 |
Why?
| Smoking Cessation | 1 | 2019 | 409 | 0.030 |
Why?
| HEK293 Cells | 1 | 2017 | 697 | 0.030 |
Why?
| Washington | 1 | 2015 | 149 | 0.030 |
Why?
| Solubility | 1 | 2015 | 232 | 0.030 |
Why?
| Area Under Curve | 1 | 2015 | 306 | 0.030 |
Why?
| Hospitalization | 1 | 2004 | 2075 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 371 | 0.030 |
Why?
| Insulin, Long-Acting | 2 | 2005 | 62 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2015 | 148 | 0.030 |
Why?
| Tunica Intima | 3 | 2000 | 84 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 122 | 0.030 |
Why?
| Achievement | 1 | 2014 | 57 | 0.030 |
Why?
| Insulin Glargine | 2 | 2005 | 81 | 0.030 |
Why?
| Epidemiologic Factors | 1 | 2013 | 8 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 180 | 0.030 |
Why?
| Antigen-Antibody Reactions | 1 | 2013 | 54 | 0.030 |
Why?
| Plaque, Atherosclerotic | 1 | 2014 | 55 | 0.030 |
Why?
| Base Sequence | 2 | 2011 | 2142 | 0.030 |
Why?
| Complement C1 Inactivator Proteins | 1 | 2012 | 6 | 0.030 |
Why?
| Complement C1 Inhibitor Protein | 1 | 2012 | 11 | 0.030 |
Why?
| Aging | 3 | 2000 | 1774 | 0.030 |
Why?
| Interleukin-10 | 1 | 2015 | 304 | 0.030 |
Why?
| S100 Calcium Binding Protein beta Subunit | 1 | 2012 | 7 | 0.030 |
Why?
| Albumins | 1 | 2013 | 104 | 0.030 |
Why?
| California | 2 | 2004 | 400 | 0.030 |
Why?
| Niacinamide | 1 | 1993 | 75 | 0.030 |
Why?
| S100 Proteins | 1 | 2012 | 35 | 0.020 |
Why?
| Comorbidity | 1 | 2017 | 1551 | 0.020 |
Why?
| Biometry | 1 | 1993 | 69 | 0.020 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 68 | 0.020 |
Why?
| Genome | 1 | 2014 | 278 | 0.020 |
Why?
| Luciferases | 1 | 2012 | 147 | 0.020 |
Why?
| Nerve Growth Factors | 1 | 2012 | 75 | 0.020 |
Why?
| Nitrates | 1 | 1992 | 88 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2012 | 156 | 0.020 |
Why?
| Phylogeny | 2 | 2006 | 845 | 0.020 |
Why?
| Water Supply | 1 | 1992 | 74 | 0.020 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 855 | 0.020 |
Why?
| Diagnostic Techniques, Endocrine | 1 | 2011 | 14 | 0.020 |
Why?
| Observation | 1 | 2011 | 51 | 0.020 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.020 |
Why?
| Residence Characteristics | 1 | 2014 | 332 | 0.020 |
Why?
| Abdominal Fat | 1 | 2012 | 40 | 0.020 |
Why?
| Adenosine Triphosphatases | 1 | 2012 | 161 | 0.020 |
Why?
| Potassium Channels | 1 | 2012 | 149 | 0.020 |
Why?
| Ubiquitins | 1 | 2011 | 36 | 0.020 |
Why?
| Societies, Medical | 1 | 2015 | 744 | 0.020 |
Why?
| Diagnosis, Differential | 2 | 2011 | 1433 | 0.020 |
Why?
| Insulinoma | 1 | 2011 | 30 | 0.020 |
Why?
| Iodine Radioisotopes | 1 | 2011 | 143 | 0.020 |
Why?
| Dietary Fats, Unsaturated | 1 | 2011 | 23 | 0.020 |
Why?
| Leptin | 1 | 2012 | 222 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 338 | 0.020 |
Why?
| Causality | 1 | 1991 | 117 | 0.020 |
Why?
| Brain | 1 | 2023 | 2677 | 0.020 |
Why?
| Peptide Fragments | 2 | 2007 | 695 | 0.020 |
Why?
| Endothelium, Vascular | 2 | 2008 | 902 | 0.020 |
Why?
| Observer Variation | 1 | 2011 | 314 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2018 | 7064 | 0.020 |
Why?
| Radioimmunoprecipitation Assay | 1 | 2009 | 6 | 0.020 |
Why?
| Staphylococcal Protein A | 1 | 2009 | 11 | 0.020 |
Why?
| Microchemistry | 1 | 2009 | 20 | 0.020 |
Why?
| Biostatistics | 1 | 2009 | 16 | 0.020 |
Why?
| DNA Replication | 1 | 2011 | 225 | 0.020 |
Why?
| Cholera Toxin | 1 | 2009 | 30 | 0.020 |
Why?
| Graves Disease | 1 | 2009 | 34 | 0.020 |
Why?
| Fetal Weight | 1 | 2009 | 55 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 505 | 0.020 |
Why?
| Intra-Abdominal Fat | 1 | 2010 | 88 | 0.020 |
Why?
| Calibration | 1 | 2009 | 140 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2010 | 379 | 0.020 |
Why?
| Pancreatic Polypeptide | 1 | 1989 | 3 | 0.020 |
Why?
| Intestinal Absorption | 1 | 2009 | 99 | 0.020 |
Why?
| Vaccination | 1 | 2017 | 1348 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 515 | 0.020 |
Why?
| Survival Rate | 2 | 2006 | 1872 | 0.020 |
Why?
| Radiography | 1 | 2011 | 797 | 0.020 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2008 | 28 | 0.020 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 48 | 0.020 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2008 | 15 | 0.020 |
Why?
| Tunica Media | 2 | 2000 | 38 | 0.020 |
Why?
| Protein Precursors | 1 | 2009 | 128 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 139 | 0.020 |
Why?
| Telecommunications | 1 | 1988 | 20 | 0.020 |
Why?
| Outpatients | 1 | 1992 | 374 | 0.020 |
Why?
| Nutrition Therapy | 1 | 2008 | 32 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 26 | 0.020 |
Why?
| Interferon-alpha | 1 | 2009 | 194 | 0.020 |
Why?
| Glucagon | 1 | 1989 | 105 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 953 | 0.020 |
Why?
| Pacific Islands | 1 | 1988 | 2 | 0.020 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.020 |
Why?
| Probability | 1 | 1989 | 304 | 0.020 |
Why?
| Americas | 1 | 1988 | 24 | 0.020 |
Why?
| Asia | 1 | 1988 | 58 | 0.020 |
Why?
| Diabetic Neuropathies | 1 | 2009 | 96 | 0.020 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 118 | 0.020 |
Why?
| Survival | 1 | 2007 | 38 | 0.020 |
Why?
| Bottle Feeding | 1 | 2007 | 21 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 41 | 0.020 |
Why?
| Vegetables | 1 | 2008 | 147 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2008 | 177 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2013 | 1368 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 1690 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 50 | 0.020 |
Why?
| Molecular Epidemiology | 1 | 2006 | 63 | 0.020 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2006 | 54 | 0.020 |
Why?
| 5' Untranslated Regions | 1 | 2006 | 56 | 0.020 |
Why?
| Protein Array Analysis | 1 | 2006 | 56 | 0.020 |
Why?
| Serotyping | 1 | 2005 | 28 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2702 | 0.020 |
Why?
| Self Care | 1 | 2009 | 368 | 0.020 |
Why?
| Sequence Alignment | 1 | 2006 | 331 | 0.020 |
Why?
| Cause of Death | 2 | 2002 | 395 | 0.010 |
Why?
| Species Specificity | 1 | 2006 | 568 | 0.010 |
Why?
| Alprostadil | 1 | 2005 | 32 | 0.010 |
Why?
| Treatment Outcome | 2 | 2004 | 10221 | 0.010 |
Why?
| Genome, Viral | 1 | 2005 | 128 | 0.010 |
Why?
| National Institutes of Health (U.S.) | 1 | 2005 | 122 | 0.010 |
Why?
| Ultrasonography | 2 | 2000 | 712 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2006 | 338 | 0.010 |
Why?
| Puerto Rico | 1 | 2004 | 52 | 0.010 |
Why?
| Polyethylene Glycols | 1 | 2009 | 612 | 0.010 |
Why?
| Dinoprostone | 1 | 2005 | 187 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 114 | 0.010 |
Why?
| Regeneration | 1 | 2005 | 182 | 0.010 |
Why?
| Mutation | 1 | 2015 | 3705 | 0.010 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 95 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 271 | 0.010 |
Why?
| Insulin Lispro | 1 | 2003 | 39 | 0.010 |
Why?
| DNA, Viral | 1 | 2005 | 347 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2008 | 2135 | 0.010 |
Why?
| Guidelines as Topic | 1 | 2005 | 264 | 0.010 |
Why?
| Duodenum | 1 | 2003 | 76 | 0.010 |
Why?
| Health | 1 | 2003 | 75 | 0.010 |
Why?
| Income | 1 | 2003 | 188 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 53 | 0.010 |
Why?
| Models, Immunological | 1 | 2002 | 96 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 191 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1985 | 416 | 0.010 |
Why?
| Cells, Cultured | 1 | 2008 | 4102 | 0.010 |
Why?
| Blotting, Southern | 1 | 2000 | 70 | 0.010 |
Why?
| Carotid Artery, Internal | 1 | 2000 | 41 | 0.010 |
Why?
| Carotid Artery, Common | 1 | 2000 | 35 | 0.010 |
Why?
| DNA, Complementary | 1 | 2000 | 266 | 0.010 |
Why?
| Cholesterol, VLDL | 1 | 1999 | 5 | 0.010 |
Why?
| Acute Disease | 1 | 2002 | 980 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 70 | 0.010 |
Why?
| Signal Transduction | 1 | 2012 | 4935 | 0.010 |
Why?
| Twins, Dizygotic | 1 | 1999 | 181 | 0.010 |
Why?
| Twins, Monozygotic | 1 | 1999 | 209 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 148 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 267 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 1098 | 0.010 |
Why?
| Demography | 1 | 1998 | 279 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2545 | 0.010 |
Why?
| Quantitative Trait, Heritable | 1 | 1997 | 121 | 0.010 |
Why?
| Cholesterol, LDL | 1 | 1998 | 358 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 233 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 412 | 0.010 |
Why?
| Mexico | 1 | 1996 | 191 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2000 | 2403 | 0.010 |
Why?
| Mental Disorders | 1 | 2002 | 1035 | 0.010 |
Why?
| Baltic States | 1 | 1992 | 1 | 0.010 |
Why?
| Computer Simulation | 1 | 1997 | 940 | 0.010 |
Why?
| Energy Metabolism | 1 | 1998 | 875 | 0.010 |
Why?
| Software | 1 | 1997 | 606 | 0.010 |
Why?
| Rats | 1 | 2000 | 5485 | 0.010 |
Why?
| Geography | 1 | 1992 | 188 | 0.010 |
Why?
| Cohort Effect | 1 | 1990 | 4 | 0.010 |
Why?
| Periodicity | 1 | 1990 | 57 | 0.010 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.000 |
Why?
| Actuarial Analysis | 1 | 1989 | 26 | 0.000 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 13 | 0.000 |
Why?
| Rubella | 1 | 1987 | 23 | 0.000 |
Why?
| Mortality | 1 | 1989 | 308 | 0.000 |
Why?
| Neoplasms | 1 | 1989 | 2454 | 0.000 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|